Juvenile myoclonic epilepsy as a possible neurodevelopmental disease: role of EFHC1 or Myoclonin1

Epilepsy Behav. 2013 Jul:28 Suppl 1:S58-60. doi: 10.1016/j.yebeh.2012.06.034.

Abstract

Juvenile Myoclonic Epilepsy (JME) accounts for almost 12% of all epilepsies and is one of the most frequent forms of genetic generalized epilepsies. Genetic studies have revealed that mutations in EFHC1 (EF-hand containing one) account for 3 to 9% of all cases around the world. This gene encodes a protein that is not an ion channel, and several studies have tried to find its cellular role. In this article, we review the various functions that have been proposed for this protein. Interestingly, all of them could affect brain development at different steps, suggesting that the developmental assembly of neural circuits may play a prominent role in JME.

Publication types

  • Review

MeSH terms

  • Animals
  • Calcium-Binding Proteins / genetics*
  • Developmental Disabilities / complications*
  • Developmental Disabilities / epidemiology
  • Developmental Disabilities / genetics*
  • Genetic Predisposition to Disease
  • Humans
  • Myoclonic Epilepsy, Juvenile / complications*
  • Myoclonic Epilepsy, Juvenile / epidemiology
  • Myoclonic Epilepsy, Juvenile / genetics*

Substances

  • Calcium-Binding Proteins
  • EFHC1 protein, human